中文 | English
Return
Total: 56 , 1/6
Show Home Prev Next End page: GO
Author:(Shu-zhan ZHENG)

1.Improvement of Determination Method for Residual Organic Solvents in Olsalazine Sodium

Zhan SHU ; Chengshuai WANG ; Lanjun ZHENG ; Binbin YING

China Pharmacist 2014;(9):1588-1589,1590

2.Detection of 18 Antihypertensive Agents Illegally Added in Traditional Chinese Medicines and Healthy Care Products by HPLC-QTOF/MS

Chengshuai WANG ; Zhan SHU ; Jie ZHU ; Lanjun ZHENG ; Binbin YING

China Pharmacist 2016;19(6):1084-1087

3.Study on PK-PD characteristics of ginsenoside Rg1 and Rb1, in rats with myocardial ischemia following intravenous administration of shengmai injection.

Shu-Yu ZHAN ; Qing SHAO ; Zheng LI ; Yi WANG ; Xiao-Hui FAN

China Journal of Chinese Materia Medica 2014;39(7):1300-1305

5.Multivariate analysis of prognostic factors in colorectal cancer patients with different ages.

Shan-rong CAI ; Shu ZHENG ; Su-zhan ZHANG

Chinese Journal of Oncology 2005;27(8):483-485

7.Effects of Matrine on hTERT-mRNA Expression and Telomerase Activity in K562 Cells

Xu-Fen LI ; Su-Zhan ZHANG ; Shu ZHENG ; Xing ZHANG

Chinese Journal of Cancer 2001;20(4):391-393

8.Mutational studies of adenomatous polyposis coli gene in carcinomas from patients with hereditary non-polyposis colorectal cancers.

Jian HUANG ; Shen-hang JIN ; Shu-zhan ZHANG ; Shu ZHENG

Chinese Journal of Medical Genetics 2003;20(3):196-199

10.Application of serum protein markers to distinguish familial adenomatous polyposis (FAP) and sporadic colorectal adenomas.

Shan-rong CAI ; Jie-kai YU ; Wen-zhi JIANG ; Su-zhan ZHANG ; Shu ZHENG

Chinese Journal of Oncology 2009;31(3):192-195

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 56 , 1/6 Show Home Prev Next End page: GO